Moriguchi, Japan

Masamichi Morimoto


Average Co-Inventor Count = 3.6

ph-index = 8

Forward Citations = 193(Granted Patents)


Location History:

  • Moriguchi, JP (1998 - 1999)
  • Kofu, JP (2003 - 2005)
  • Koufu, JP (2006)
  • Osaka, JP (1989 - 2009)

Company Filing History:


Years Active: 1989-2009

Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Masamichi Morimoto

Introduction

Masamichi Morimoto, a prominent inventor based in Moriguchi, Japan, has made significant strides in the field of pharmaceuticals, holding a remarkable 14 patents to his name. His innovative work primarily focuses on the development of novel chemical compounds with therapeutic potential.

Latest Patents

Among his recent innovations are two notable patents:

1. **Carbamoyl-type benzofuran derivatives** - This invention outlines a carbamoyl-type benzofuran derivative formula designed for use as an FXa inhibitor. The detailed structure includes various groups that contribute to its efficacy, such as cycloalkanediyl groups and an optionally substituted benzene ring.

2. **Amide type carboxamide derivative** - This derivative also serves as an FXa inhibitor. The patent provides a complex formula involving phenyl groups and various substituents, showcasing Morimoto's expertise in pharmaceutical chemistry.

Career Highlights

Masamichi Morimoto has worked for leading companies in the pharmaceutical industry, including Matsushita Electric Industrial Co., Ltd. and Mitsubishi Tanabe Pharma Corporation. His experience in these organizations has equipped him with the knowledge and skills necessary for his innovative contributions.

Collaborations

Throughout his career, Morimoto collaborated with talented colleagues such as Kazumasa Okumura and Junichi Hada. These partnerships have likely enhanced his innovative processes and broadened the scope of his research.

Conclusion

Masamichi Morimoto's work exemplifies the spirit of innovation central to the pharmaceutical industry. With 14 patents under his belt, including his latest achievements in FXa inhibition, he continues to contribute valuable advancements that hold significant promise for medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…